본문 바로가기
KERD
논문KCI 등재

Microbial infections in burn patients

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Polymicrobial infections are the leading causes of complications incurred from injuries that burn patients develop. Such patients admitted to the hospital have a high risk of developing hospital-acquired infections, with longer patient stays leading to increased chances of acquiring such drug-resistant infections. Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis are the most common multidrug-resistant (MDR) Gram-negative bacteria identified in burn wound infections (BWIs). BWIs caused by viruses, like Herpes Simplex and Varicella Zoster, and fungi-like Candida spp. appear to occur occasionally. However, the preponderance of infection by opportunistic pathogens is very high in burn patients. Variations in the causative agents of BWIs are due to differences in geographic location and infection control measures. Overall, burn injuries are characterized by elevated serum cytokine levels, systemic immune response, and immunosuppression. Hence, early detection and treatment can accelerate the wound-healing process and reduce the risk of further infections at the site of injury. A multidisciplinary collaboration between burn surgeons and infectious disease specialists is also needed to properly monitor antibiotic resistance in BWI pathogens, help check the super-spread of MDR pathogens, and improve treatment outcomes as a result.

Abstract

Polymicrobial infections are the leading causes of complications incurred from injuries that burn patients develop. Such patients admitted to the hospital have a high risk of developing hospital-acquired infections, with longer patient stays leading to increased chances of acquiring such drug-resistant infections. Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis are the most common multidrug-resistant (MDR) Gram-negative bacteria identified in burn wound infections (BWIs). BWIs caused by viruses, like Herpes Simplex and Varicella Zoster, and fungi-like Candida spp. appear to occur occasionally. However, the preponderance of infection by opportunistic pathogens is very high in burn patients. Variations in the causative agents of BWIs are due to differences in geographic location and infection control measures. Overall, burn injuries are characterized by elevated serum cytokine levels, systemic immune response, and immunosuppression. Hence, early detection and treatment can accelerate the wound-healing process and reduce the risk of further infections at the site of injury. A multidisciplinary collaboration between burn surgeons and infectious disease specialists is also needed to properly monitor antibiotic resistance in BWI pathogens, help check the super-spread of MDR pathogens, and improve treatment outcomes as a result.

참고문헌 (84)

  1. Mohapatra S, "Bacteriological profiles in burn patients within first twenty-four hours of injury", Int J Med Microbiol Trop Dis, 2, pp.71~74 (2016)
  2. Chen YY, "Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center", BMC Infect Dis, 20, pp.193~ (2020)
  3. Maslova E, "Burns and biofilms : priority pathogens and in vivo models", NPJ Biofilms Microbiomes, 7, pp.73~ (2021)
  4. López-Jácome LE, "Microbiology and infection profile of electric burned patients in a referral burn hospital in Mexico City", J Burn Care Res, 41, pp.390~397 (2020)
  5. Forjuoh SN, "Burns in low-and middle-income countries : a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention", Burns, 32, pp.529~537 (2006)
  6. Peck MD, "Epidemiology of burns throughout the world. Part I: distribution and risk factors", Burns, 37, pp.1087~1100 (2011)
  7. Ho WS, "An epidemiological study of 1063 hospitalized burn patients in a tertiary burns centre in Hong Kong", Burns, 27, pp.119~123 (2001)
  8. Opriessnig E, "Epidemiology of burn injury and the ideal dressing in global burn care : regional differences explored", Burns, 49, pp.1~14 (2023)
  9. Peck MD, "Epidemiology of burns throughout the World. Part II: intentional burns in adults", Burns, 38, pp.630~637 (2012)
  10. Kara YA, "Hot topics in burn injuries" (2018), Intechope
  11. Elsous A, "Epidemiology and outcomes of hospitalized burn patients in Gaza strip : a descriptive study", Ethiop J Health Sci, 26, pp.9~16 (2016)
  12. Bhardwaj S, "Growing emergence of drug-resistant Pseudomonas aeruginosa and attenuation of its virulence using quorum sensing inhibitors : a critical review", Iran J Basic Med Sci, 24, pp.699~719 (2021)
  13. Jeschke MG, "Burn injury", Nat Rev Dis Primers, 6, pp.11~ (2020)
  14. Norbury W, "Infection in burns", Surg Infect(Larchmt), 17, pp.250~255 (2016)
  15. El Hamzaoui N, "Epidemiology of burn wound bacterial infections at a Meknes hospital, Morocco", New Microbes New Infect, 38, pp.100764~ (2020)
  16. Thabet L, "Surveillance of multidrug resistant bacteria in a Tunisian hospital", Tunis Med, 86, pp.992~995 (2008)
  17. Thabet L, "Bacteriological profile and antibiotic resistance of bacteria isolates in a burn department", Tunis Med, 86, pp.1051~1054 (2008)
  18. von Baum H, "Antibiotic-resistant bloodstream infections in hospitalized patients : specific risk factors in a high-risk population?", Infection, 33, pp.320~326 (2005)
  19. Wilson GR, "Loss of split thickness skin grafts due to non-group A beta-haemolytic streptococci", Ann R Coll Surg Engl, 70, pp.217~219 (1988)
  20. Williams FN, "The leading causes of death after burn injury in a single pediatric burn center", Crit Care, 13, pp.R183~ (2009)
  21. McManus AT, "Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center", Eur J Clin Microbiol, 4, pp.219~223 (1985)
  22. Walton MA, "The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa", Burns, 23, pp.225~227 (1997)
  23. Corbella X, "Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii", J Clin Microbiol, 38, pp.4086~4095 (2000)
  24. Thomas RE, "Reducing biofilm infections in burn patients' wounds and biofilms on surfaces in hospitals, medical facilities and medical equipment to improve burn care : a systematic review", Int J Environ Res Public Health, 18, pp.13195~ (2021)
  25. Khan BA, "Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections", Expert Opin Investig Drugs, 24, pp.689~704 (2015)
  26. Ramakrishnan M, "Study on biofilm formation in burn wound infection in a pediatric hospital in Chennai, India", Ann Burns Fire Disasters, 29, pp.276~280 (2016)
  27. Avni T, "Prophylactic antibiotics for burns patients : systematic review and meta-analysis", BMJ, 340, pp.c241~ (2010)
  28. Falagas ME, "The diversity of definitions of multidrug-resistant(MDR)and pandrug-resistant(PDR)Acinetobacter baumannii and Pseudomonas aeruginosa", J Med Microbiol, 55(Pt 12), pp.1619~1629 (2006)
  29. Gupta M, "Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital", Heliyon, 5, pp.e02956~ (2019)
  30. "Burn patients often have higher rates of multidrug-resistant infections—but there are ways to help" (2023)[URL]
  31. Lachiewicz AM, "Bacterial infections after burn injuries : impact of multidrug resistance", Clin Infect Dis, 65, pp.2130~2136 (2017)
  32. Wanis M, "Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center", Burns, 42, pp.104~111 (2016)
  33. Sheridan R, "Multi-drug resistant Gram-negative bacteria colonization and infection in burned children : lessons learned from a 20-year experience", Burns Open, 2, pp.43~46 (2018)
  34. Rosanova MT, "Risk factors for mortality in burn children", Braz J Infect Dis, 18, pp.144~149 (2014)
  35. Taneja N, "A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India", Burns, 30, pp.665~669 (2004)
  36. Kabanangi F, "High level of multidrug-resistant gram-negative pathogens causing burn wound infections in hospitalized children in Dar es Salaam, Tanzania", Int J Microbiol, 2021, pp.6644185~ (2021)
  37. Magiorakos AP, "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria : an international expert proposal for interim standard definitions for acquired resistance", Clin Microbiol Infect, 18, pp.268~281 (2012)
  38. Gupta N, "Epidemiology and molecular typing of Candida isolates from burn patients", Mycopathologia, 158, pp.397~405 (2004)
  39. Horvath EE, "Fungal wound infection(not colonization)is independently associated with mortality in burn patients", Ann Surg, 245, pp.978~985 (2007)
  40. Mousa HA, "Fungal infection of burn wounds in patients with open and occlusive treatment methods", East Mediterr Health J, 5, pp.333~336 (1999)
  41. Ahmad S, "Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait", Med Mycol, 41, pp.487~493 (2003)
  42. Murray CK, "Incidence of systemic fungal infection and related mortality following severe burns", Burns, 34, pp.1108~1112 (2008)
  43. Becker WK, "Fungal burn wound infection : a 10-year experience", Arch Surg, 126, pp.44~48 (1991)
  44. Ballard J, "Positive fungal cultures in burn patients : a multicenter review", J Burn Care Res, 29, pp.213~221 (2008)
  45. Greenhalgh DG, "American Burn Association consensus conference to define sepsis and infection in burns", J Burn Care Res, 28, pp.776~790 (2007)
  46. Mathew BP, "Recent approaches to antifungal therapy for invasive mycoses", ChemMedChem, 4, pp.310~323 (2009)
  47. Dries DJ, "Management of burn injuries : recent developments in resuscitation, infection control and outcomes research", Scand J Trauma Resusc Emerg Med, 17, pp.14~ (2009)
  48. Struck MF, "Infection control in burn patients : are fungal infections underestimated?", Scand J Trauma Resusc Emerg Med, 17, pp.51~56 (2009)
  49. de Macedo JL, "Bacterial and fungal colonization of burn wounds", Mem Inst Oswaldo Cruz, 100, pp.535~539 (2005)
  50. Church D, "Burn wound infections", Clin Microbiol Rev, 19, pp.403~434 (2006)
  51. Capoor MR, "Fungal infections in burns : diagnosis and management", Indian J Plast Surg, 43(Suppl), pp.S37~S42 (2010)
  52. (2002)[URL]
  53. Mousa HA, "Aerobic, anaerobic and fungal burn wound infections", J Hosp Infect, 37, pp.317~323 (1997)
  54. Baj J, "Viral infections in burn patients : a state-of-the-art review", Viruses, 12, pp.1315~ (2020)
  55. Xu H, "Herpes simplex virus 1 UL24 abrogates the DNA sensing signal pathway by inhibiting NF-κB activation", J Virol, 91, pp.e00025–17~ (2017)
  56. Wood JJ, "Abnormalities of antibody production after thermal injury : an association with reduced interleukin 2 production", Arch Surg, 121, pp.108~115 (1986)
  57. Haik J, "Is prophylactic acyclovir treatment warranted for prevention of herpes simplex virus infections in facial burns? A review of the literature", J Burn Care Res, 32, pp.358~362 (2011)
  58. Rennekampff HO, "Cytomegalovirus infection in burns : a review", J Med Microbiol, 55, pp.483~487 (2006)
  59. Schwacha MG, "Macrophages and post-burn immune dysfunction", Burns, 29, pp.1~14 (2003)
  60. Bordes J, "Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction : a prospective study", Burns, 37, pp.434~439 (2011)
  61. Wurzer P, "Human herpes viruses in burn patients : a systematic review", Burns, 43, pp.25~33 (2017)
  62. Sheridan RL, "A 15-year experience with varicella infections in a pediatric burn unit", Burns, 25, pp.353~356 (1999)
  63. Midilli K, "Nosocomial outbreak of disseminated orf infection in a burn unit, Gaziantep, Turkey, October to December 2012", Euro Surveill, 18, pp.20425~ (2013)
  64. Bergqvist C, "Orf virus infection", Rev Med Virol, 27 (2017)
  65. Al-Qattan MM, "Orf infection of the hand", J Hand Surg Am, 36, pp.1855~1858 (2011)
  66. Edge JM, "Clinical outcome of HIV positive patients with moderate to severe burns", Burns, 27, pp.111~114 (2001)
  67. Allgöwer M, "Burning the largest immune organ", Burns, 21(Suppl 1), pp.S7~S47 (1995)
  68. Camilleri IG, "Human papilloma virus proliferation in a healing burn", Burns, 22, pp.162~163 (1996)
  69. Espinoza LF, "Geographic variation in outcomes after burn injury : a burn model system national database study", Ann Plast Surg, 84, pp.644~650 (2020)
  70. Gupta VK, "Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity", Front Microbiol, 8, pp.1162~ (2017)
  71. Ozumba UC, "Bacteriology of burn wounds in Enugu, Nigeria", Burns, 26, pp.178~180 (2000)
  72. Laura P, "Impact of COVID-19 on global burn care", Burns, 48, pp.1301~1310 (2022)
  73. Sierawska O, "Innate immune system response to burn damage-focus on cytokine alteration", Int J Mol Sci, 23, pp.716~ (2022)
  74. Vinish M, "Dendritic cells modulate burn wound healing by enhancing early proliferation", Wound Repair Regen, 24, pp.6~13 (2016)
  75. Rani M, "Aging and the pathogenic response to burn", Aging Dis, 3, pp.171~180 (2012)
  76. Grogan JB, "Altered neutrophil phagocytic function in burn patients", J Trauma, 16, pp.734~738 (1976)
  77. Rich RR, "Clinical immunology principles and practices" (2001), Mosby
  78. Altman LC, "Depressed mononuclear leukocyte chemotaxis in thermally injured patients", J Immunol, 119, pp.199~205 (1977)
  79. Moins-Teisserenc H, "Severe altered immune status after burn injury is associated with bacterial infection and septic shock", Front Immunol, 12, pp.586195~ (2021)
  80. Coban YK, "Infection control in severely burned patients", World J Crit Care Med, 1, pp.94~101 (2012)
  81. Boyce JM, "Burn units as a source of methicillin-resistant Staphylococcus aureus infections", JAMA, 249, pp.2803~2807 (1983)
  82. Wolvos T, "Wound instillation: the next step in negative pressure wound therapy. Lessons learned from initial experiences", Ostomy Wound Manage, 50, pp.56~66 (2004)
  83. Wilson JR, "A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes", Adv Skin Wound Care, 18, pp.373~378 (2005)
  84. Coban YK, "Our 18-month experience at a new burn center in Gaziantep, Turkey", Ulus Travma Acil Cerrahi Derg, 16, pp.353~356 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (16건)